top of page
AAO 2025: ANTERIOR SEGMENT SHOWCASE
Moderators: Kuldev Singh, MD, MPH, Program Co-Chair and Julie M. Schallhorn, MD, MS, Program Committee
Panel: Damien Gatinel, MD, PhD, Head, Anterior Segment and Refractive Surgery, Rothschild Foundation Hospital, Sarah H. Van Tassel, MD, Associate Professor of Ophthalmology, Director, Glaucoma Service, Weill Cornell Medicine, and Ryan Zimmerman, MHA, Managing Director, Equity Research–Medical Technology, BTIG
Room: W221
Start | Company | Presenter |
|---|---|---|
1:15 PM | Introduction | Julie Schallhorn, MD, MS |
1:16 PM | Emmecell | Jeffrey L. Goldberg, MD, PhD, Director, Board of Managers |
1:21 PM | Precise Bio | Aryeh Batt, CEO & Co-founder |
1:26 PM | Discussion | |
1:29 PM | Signal12 | Thomas Mitro, CEO |
1:34 PM | Iolyx Therapeutics | Elizabeth Jeffords, CEO |
1:39 PM | Discussion | |
1:42 PM | Tenpoint Therapeutics | Ben Bergo, President & Chief Business Officer |
1:47 PM | Theialife inc. | Patricia Zilliox, Ph.D., Advisor |
1:52 PM | Discussion | |
1:55 PM | Qlaris Bio, Inc. | Barbara Wirostko, MD, Chief Medical Officer |
2:00 PM | Heru | Mohamed Abou Shousha, MD, PhD, CEO |
2:05 PM | Discussion | |
2:08 PM | Perfuse Therapeutics | Phillip Lai, Chief Medical Officer |
2:13 PM | Smartlens, Inc. | Savas Komban, CEO |
2:18 PM | ViaLase Inc | Pete England, Chief Commerical Officer |
2:23 PM | Discussion | |
2:28 PM | Bausch + Lomb | Yehia Hashad, MD, EVP, Research & Development & Chief Medical Officer |
2:33 PM | Stuart Therapeutics | Eric Schlumpf, President & CEO |
2:38 PM | Discussion | |
2:41 PM | Conclusion | Kuldev Singh, MD |
2:42 PM | End of Session |
Anchor 1
bottom of page